Vivos Therapeutics (VVOS) FCF Margin Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 60.00 |
| 10 | Vivos Therapeutics | 4.89 Mn | 3.09 Mn | 2.95 Mn | 2,151.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,401.00 |
| Dec 31, 2025 | -13,147.00 |
| Sep 30, 2025 | 7,925.00 |
| Jun 30, 2025 | 1,169.00 |
| Mar 31, 2025 | 4,016.00 |
| Dec 31, 2024 | 1,830.00 |
| Sep 30, 2024 | -1,454.00 |
| Jun 30, 2024 | 3,474.00 |
| Mar 31, 2024 | 4,157.00 |
| Dec 31, 2023 | 592.00 |
| Sep 30, 2023 | -5,082.00 |
| Jun 30, 2023 | -6,770.00 |
| Mar 31, 2023 | -7,922.00 |